Galectin Therapeutics Announces Closing Of $10 Million In Debt Financing From Its Chairman, Richard E. Uihlein
Round Type
Debt Financing
NorcrossBiotechnologyHealthcareHealth CareTherapeuticsDescription
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that it has closed on the second $10 million convertible note pursuant to a financing agreement entered in September, 2021, with Richard E. Uihlein, the Company’s Chairman and largest individual stockholder. In total, the Company has received $30 million in three convertible notes from Mr
Quick answer
Galectin raised an undisclosed amount in a Debt Financing round, dated December 21, 2021. Galectin is based in Norcross, Georgia, United States.
- How much did Galectin raise?
- Galectin raised an undisclosed amount in a Debt Financing round on December 21, 2021.
- What does Galectin do?
- The NAVIGATE trial (NAVIGATEnash.com), entitled “A Seamless Adaptive Phase 2b/3, Double-Blind, Randomized, Placebo-controlled Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02)..
- Where is Galectin based and how big is it?
- Galectin is based in Norcross, Georgia, United States. Fundz records about 15 employees.
- Who are the decision-makers at Galectin?
- Fundz holds 2 contacts at Galectin, including the Senior Director Project Management. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Therapeutics around the same time
Companies in the same sectors as Galectin that raised within 45 days of this round, from Fundz verified event records.
- MindImmune Therapeutics raised $5.3M on February 4, 2022.
- Passage Bio raised $4M (Seed) on February 1, 2022.
- Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
- Tessera Defense & Homeland Security Inc. raised $3M (Seed) on January 4, 2022.
- Arbutus raised $15M on December 30, 2021.
- Biofrontera raised $15M on December 10, 2021.
Who to call at Galectin, and when
A new round usually means Galectin is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Galectin raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Galectin, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Galectin. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Galectin raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Galectin raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.